Pacific Biosciences of California, Inc. Stock
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.605 USD | -10.17% |
|
+23.46% | +39.30% |
| Market Cap | 810M 725M 667M 604M 1.13B 76.88B 1.15B 7.95B 3.19B 40.44B 3.04B 2.97B 128B | P/E 2026 * |
-5.85x | P/E 2027 * | -5.66x |
|---|---|---|---|---|---|
| Enterprise Value | 1.28B 1.15B 1.05B 954M 1.78B 121B 1.82B 12.56B 5.04B 63.86B 4.8B 4.7B 201B | EV / Sales 2026 * |
8.06x | EV / Sales 2027 * | 7.26x |
| Free-Float |
91.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PACB | Delayed | |
CBOE
| PACB | Real-time | |
|
Tradegate
| P09 | Real-time | |
|
Börse Stuttgart
| P09 | Delayed | |
|
Boerse Muenchen
| P09 | Real-time | |
|
Xetra
| P09 | Delayed | |
|
Deutsche Boerse AG
| P09 | Delayed | |
|
Mexican S.E.
| PACB * | End-of-day quote |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | -10.17% | ||
| 1 week | +23.46% | ||
| 1 month | +9.92% | ||
| 3 months | +86.07% | ||
| 6 months | +63.84% | ||
| Current year | +39.30% |
| 1 week | 2.08 |  | 3.06 |
| 1 month | 1.7 | | 3.44 |
| Current year | 1.07 | | 3.44 |
| 1 year | 1.07 | | 3.44 |
| 3 years | 0.85 | | 10.65 |
| 5 years | 0.85 | | 31.1 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark van Oene
CEO | Chief Executive Officer | 53 | 05/08/2026 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 31/03/2025 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 01/01/2004 |
Randy Livingston
BRD | Director/Board Member | 72 | 01/01/2009 |
Marshall Mohr
BRD | Director/Board Member | 69 | 18/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/10/26 | Exercice | Chief Financial Officer | 1,661,815 | 0.5346% | ||
| 17/8/26 | Sell | Chief Executive Officer | -26,911 | 0.0087% | ||
| 10/8/26 | Free | Chief Executive Officer | 2,457,018 | 0.7911% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.17% | +23.46% | +11.32% | -57.85% | 810M | |
| -1.72% | +3.44% | +22.84% | +56.71% | 258B | |
| -2.00% | +0.75% | +7.82% | +20.94% | 163B | |
| -3.73% | -4.48% | -19.14% | +64.75% | 150B | |
| -1.66% | -8.12% | -58.32% | -17.99% | 60.84B | |
| -.--% | +2.46% | -11.69% | -7.41% | 53.31B | |
| -2.57% | +3.30% | +11.59% | +44.40% | 53.03B | |
| +0.84% | -3.12% | +7.47% | +62.40% | 50.67B | |
| -3.47% | +1.04% | +19.48% | +69.17% | 49.3B | |
| -3.61% | +1.99% | +32.36% | +93.99% | 45.46B | |
| Average | -2.81% | +2.07% | +2.37% | +32.91% | 88.48B | |
| Weighted average by Cap. | -2.11% | +0.17% | +4.04% | +44.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 159M 142M 131M 118M 221M 15.07B 226M 1.56B 626M 7.93B 596M 583M 25B | 184M 165M 152M 137M 257M 17.48B 262M 1.81B 726M 9.2B 691M 676M 29B |
| Net income | -138M -124M -114M -103M -193M -13.11B -196M -1.36B -544M -6.89B -518M -507M -21.74B | -147M -132M -121M -110M -205M -13.96B -209M -1.44B -580M -7.35B -552M -540M -23.16B |
| Net Debt | 469M 420M 386M 350M 654M 44.52B 667M 4.61B 1.85B 23.42B 1.76B 1.72B 73.86B | 527M 472M 434M 393M 735M 50B 748M 5.17B 2.08B 26.3B 1.98B 1.93B 82.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$2.605 | -10.17% | 13,737,066 |
| 29/10/26 | US$2.900 | +2.47% | 11,974,067 |
| 28/10/26 | US$2.830 | +15.51% | 35,046,710 |
| 27/10/26 | US$2.450 | +8.89% | 18,685,362 |
| 26/10/26 | US$2.250 | +6.64% | 9,572,726 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
